loadpatents
Patent applications and USPTO patent grants for DUNCTON; Matthew.The latest application filed is for "thienyl-aniline compounds for treatment of dermal disorders".
Patent | Date |
---|---|
Thienyl-aniline Compounds For Treatment Of Dermal Disorders App 20220204486 - KINCAID; John ;   et al. | 2022-06-30 |
Naphthyridinone-aniline Compounds For Treatment Of Dermal Disorders App 20220144819 - KINCAID; John ;   et al. | 2022-05-12 |
Direct Ampk Activators App 20220098175 - Shaw; Simon ;   et al. | 2022-03-31 |
Nrf2 activating compounds and uses thereof Grant 11,279,686 - Duncton , et al. March 22, 2 | 2022-03-22 |
Pyrrolopyridine-aniline Compounds For Treatment Of Dermal Disorders App 20220033399 - Kincaid; John ;   et al. | 2022-02-03 |
Cyanoaryl-aniline Compounds For Treatment Of Dermal Disorders App 20220009887 - KINCAID; John ;   et al. | 2022-01-13 |
Fused Heteroaromatic-aniline Compounds For Treatment Of Dermal Disorders App 20210380601 - KINCAID; John ;   et al. | 2021-12-09 |
Direct AMPK activators Grant 11,174,246 - Shaw , et al. November 16, 2 | 2021-11-16 |
Pyrrolopyridine-aniline compounds for treatment of dermal disorders Grant 11,161,845 - Kincaid , et al. November 2, 2 | 2021-11-02 |
Fumarate analogs and uses thereof Grant 11,129,819 - Duncton , et al. September 28, 2 | 2021-09-28 |
Fused heteroaromatic-aniline compounds for treatment of dermal disorders Grant 10,988,483 - Kincaid , et al. April 27, 2 | 2021-04-27 |
Nrf2 Activating Compounds and Uses Thereof App 20210078969 - Duncton; Matthew ;   et al. | 2021-03-18 |
Nrf2 activating compounds and uses thereof Grant 10,941,135 - Duncton , et al. March 9, 2 | 2021-03-09 |
Nrf2 activating compounds and uses thereof Grant 10,844,040 - Duncton , et al. November 24, 2 | 2020-11-24 |
Nrf2 Activating Compounds and Uses Thereof App 20200339538 - Duncton; Matthew ;   et al. | 2020-10-29 |
Protein kinase C inhibitors and uses thereof Grant 10,792,282 - Singh , et al. October 6, 2 | 2020-10-06 |
Nrf2 Activating Compounds and Uses Thereof App 20200216412 - Duncton; Matthew ;   et al. | 2020-07-09 |
Fused Heteroaromatic-aniline Compounds For Treatment Of Dermal Disorders App 20200172550 - Kincaid; John ;   et al. | 2020-06-04 |
Pyrrolopyridine-aniline Compounds For Treatment Of Dermal Disorders App 20200165243 - Kincaid; John ;   et al. | 2020-05-28 |
Fumarate Analogs and Uses Thereof App 20200155531 - Duncton; Matthew ;   et al. | 2020-05-21 |
Nrf2 activating compounds and uses thereof Grant 10,647,697 - Duncton , et al. | 2020-05-12 |
Nrf2 activating compounds and uses thereof Grant 10,556,881 - Duncton , et al. Feb | 2020-02-11 |
Fumarate analogs and uses thereof Grant 10,493,066 - Duncton , et al. De | 2019-12-03 |
Tetrazolones as a carboxylic acid bioisosteres Grant 10,450,280 - Duncton , et al. Oc | 2019-10-22 |
Protein Kinase C Inhibitors and Uses Thereof App 20190060310 - Singh; Rajinder ;   et al. | 2019-02-28 |
Nrf2 Activating Compounds and Uses Thereof App 20180258070 - Duncton; Matthew ;   et al. | 2018-09-13 |
Nrf2 Activating Compounds and Uses Thereof App 20180258063 - Duncton; Matthew ;   et al. | 2018-09-13 |
Protein kinase C inhibitors and uses thereof Grant 10,005,777 - Singh , et al. June 26, 2 | 2018-06-26 |
Fumarate Analogs and Uses Thereof App 20180071271 - Duncton; Matthew ;   et al. | 2018-03-15 |
Protein kinase C inhibitors and uses thereof Grant 9,913,843 - Kolluri , et al. March 13, 2 | 2018-03-13 |
Direct Ampk Activators App 20180051006 - Shaw; Simon ;   et al. | 2018-02-22 |
Protein Kinase C Inhibitors and Uses Thereof App 20180030050 - Singh; Rajinder ;   et al. | 2018-02-01 |
Tetrazolones as a Carboxylic Acid Bioisosteres App 20180002297 - Duncton; Matthew ;   et al. | 2018-01-04 |
Protein Kinase C Inhibitors and Uses Thereof App 20170360786 - Singh; Rajinder ;   et al. | 2017-12-21 |
Nrf2 activating compounds and uses thereof Grant 9,845,311 - Duncton , et al. December 19, 2 | 2017-12-19 |
Nrf2 activating compounds and uses thereof Grant 9,845,307 - Duncton , et al. December 19, 2 | 2017-12-19 |
Fumarate analogs and uses thereof Grant 9,801,866 - Duncton , et al. October 31, 2 | 2017-10-31 |
Protein kinase C inhibitors and uses thereof Grant 9,732,070 - Singh , et al. August 15, 2 | 2017-08-15 |
Nrf2 Activating Compounds and Uses Thereof App 20170217922 - Duncton; Matthew ;   et al. | 2017-08-03 |
Nrf2 Activating Compounds and Uses Thereof App 20170217932 - Duncton; Matthew ;   et al. | 2017-08-03 |
Tetrazolones as a carboxylic acid bioisosteres Grant 9,701,647 - Duncton , et al. July 11, 2 | 2017-07-11 |
Protein kinase C inhibitors and uses thereof Grant 9,682,976 - Singh , et al. June 20, 2 | 2017-06-20 |
Protein Kinase C Inhibitors and Uses Thereof App 20170152246 - Singh; Rajinder ;   et al. | 2017-06-01 |
Tetrazolones as a Carboxylic Acid Bioisosteres App 20170129862 - Duncton; Matthew ;   et al. | 2017-05-11 |
Fumarate Analogs and Uses Thereof App 20170065569 - Duncton; Matthew ;   et al. | 2017-03-09 |
Protein kinase C inhibitors and uses thereof Grant 9,566,278 - Singh , et al. February 14, 2 | 2017-02-14 |
Fumarate analogs and uses thereof Grant 9,475,781 - Duncton , et al. October 25, 2 | 2016-10-25 |
Tetrazolones as a carboxylic acid bioisosteres Grant 9,439,888 - Duncton , et al. September 13, 2 | 2016-09-13 |
Protein Kinase C Inhibitors and Uses Thereof App 20160257681 - Singh; Rajinder ;   et al. | 2016-09-08 |
Tetrazolones as a Carboxylic Acid Bioisosteres App 20160213648 - Duncton; Matthew ;   et al. | 2016-07-28 |
Protein kinase C inhibitors and uses thereof Grant 9,321,763 - Singh , et al. April 26, 2 | 2016-04-26 |
Protein Kinase C Inhibitors and Uses Thereof App 20160058760 - Singh; Rajinder ;   et al. | 2016-03-03 |
Fumarate Analogs And Uses Thereof App 20160039773 - Duncton; Matthew ;   et al. | 2016-02-11 |
Protein kinase C inhibitors and uses thereof Grant 9,181,222 - Holland , et al. November 10, 2 | 2015-11-10 |
Protein Kinase C Inhibitors And Uses Thereof App 20150306100 - Kolluri; Rao ;   et al. | 2015-10-29 |
Protein kinase C inhibitors and uses thereof Grant 9,169,249 - Singh , et al. October 27, 2 | 2015-10-27 |
Protein kinase C inhibitors and uses thereof Grant 9,149,475 - Singh , et al. October 6, 2 | 2015-10-06 |
Cyclopropyl MIDA boronate Grant 9,108,990 - Duncton , et al. August 18, 2 | 2015-08-18 |
Protein kinase C inhibitors and uses thereof Grant 9,062,068 - Kolluri , et al. June 23, 2 | 2015-06-23 |
Protein Kinase C Inhibitors and Uses Thereof App 20140329842 - Holland; Sacha ;   et al. | 2014-11-06 |
Cyclopropyl MIDA Boronate App 20140296557 - Duncton; Matthew ;   et al. | 2014-10-02 |
Protein Kinase C Inhibitors and Uses Thereof App 20140275055 - Singh; Rajinder ;   et al. | 2014-09-18 |
Cyclopropyl PIDA boronate Grant 8,754,251 - Duncton , et al. June 17, 2 | 2014-06-17 |
Protein Kinase C Inhibitors And Uses Thereof App 20140163022 - Kolluri; Rao ;   et al. | 2014-06-12 |
Cyclopropyl MIDA boronate Grant 8,722,916 - Duncton , et al. May 13, 2 | 2014-05-13 |
Protein kinase C inhibitors and uses thereof Grant 8,710,223 - Holland , et al. April 29, 2 | 2014-04-29 |
Cyclopropyl Pida Boronate App 20130331585 - Duncton; Matthew ;   et al. | 2013-12-12 |
Protein Kinase C Inhibitors and Uses Thereof App 20130331374 - Singh; Rajinder ;   et al. | 2013-12-12 |
Protein Kinase C Inhibitors and Uses Thereof App 20130210810 - Singh; Rajinder ;   et al. | 2013-08-15 |
Amide Derivatives As Ion-channel Ligands And Pharmaceutical Compositions And Methods Of Using The Same App 20130045973 - Duncton; Matthew ;   et al. | 2013-02-21 |
Protein kinase C inhibitors and uses thereof Grant 8,377,924 - Singh , et al. February 19, 2 | 2013-02-19 |
2-cyanophenyl Fused Heterocyclic Compounds, And Compostions And Uses Thereof App 20120149700 - WEI; Zhi-Liang ;   et al. | 2012-06-14 |
Cyclopropyl Mida Boronate App 20120142915 - Duncton; Matthew ;   et al. | 2012-06-07 |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same Grant 8,163,901 - Duncton , et al. April 24, 2 | 2012-04-24 |
Protein Kinase C Inhibitors And Uses Thereof App 20120022092 - Holland; Sacha ;   et al. | 2012-01-26 |
2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof Grant 8,076,345 - Wei , et al. December 13, 2 | 2011-12-13 |
Compounds Useful As Faah Modulators And Uses Thereof App 20110257208 - Duncton; Matthew ;   et al. | 2011-10-20 |
Protein Kinase C Inhibitors And Uses Thereof App 20110130415 - Singh; Rajinder ;   et al. | 2011-06-02 |
Amide Derivatives As Ion-channel Ligands And Pharmaceutical Compositions And Methods Of Using The Same App 20110028465 - Duncton; Matthew ;   et al. | 2011-02-03 |
Protein Kinase C Inhibitors And Uses Thereof App 20100204208 - Singh; Rajinder ;   et al. | 2010-08-12 |
Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same App 20100004222 - Kelly; Michael G. ;   et al. | 2010-01-07 |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same Grant 7,576,099 - Kelly , et al. August 18, 2 | 2009-08-18 |
Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same App 20080300243 - Kelly; Michael G. ;   et al. | 2008-12-04 |
2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof App 20080275037 - Wei; Zhi-Liang ;   et al. | 2008-11-06 |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same App 20080096919 - Kelly; Michael G. ;   et al. | 2008-04-24 |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same Grant 7,312,233 - Kelly , et al. December 25, 2 | 2007-12-25 |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same App 20060205773 - Kelly; Michael G. ;   et al. | 2006-09-14 |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same App 20060194801 - Kelly; Michael G. ;   et al. | 2006-08-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.